17 reports

In 2013, FDA approved Sitavig, an antiviral buccal tablet for the treatment of herpes labialis in adults.

  • Opioid
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.

APPROXIMATELY ## HEALTHY, HIV-UNINFECTED WOMEN AGES ##-## WHO ARE NOT PREGNANT WILL BE RANDOMLY ASSIGNED TO ONE OF THREE GROUPS: ONE GROUP WILL USE A VAGINAL RING DESIGNED FOR THREE-MONTH USE THAT CONTAINS ## MG DAPIVIRINE; ONE GROUP WILL USE A RING ALSO DESIGNED FOR THRE

  • Anesthetics
  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Clinical Trial
  • Opioid
  • Therapy
  • World
  • Product Initiative

Each unit is comprised of one common share (or common share equivalent) and one warrant to purchase one common share.

  • Opioid
  • Canada
  • United States
  • Corporate Finance
  • Intellipharmaceutics International Inc.

Therapy Area Cardiovascular Central Nervous System Dermatology Gastrointestinal Infectious Disease Metabolic Disorders Musculoskeletal Oncology Respiratory No. of Deals ## ## ## ## ## ## ## ## ## Deal Value (US$ million) NA NA N

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Opioid
  • World
  • Product Initiative
  • Indivior PLC
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Opioid
  • World
  • Merck & Co., Inc.
  • OSTEOPOROSIS, BREAST CANCER PREVENTION

APPENDIX ##: TABULATED DATA ##.

  • Opioid
  • North America
  • United States
  • Demand
  • Market Size

Earlier one year ago, CSL paid USD## million for an ##% stake in RuiDe.

  • Opioid
  • China
  • United States
  • Corporate Finance
  • M&A

There are four types of anti-infectives: antibacterial, antiviral, antitubercular, and antifungal.

  • Anti-Infective
  • Opioid
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • 5. All the trials included are unique trials.

## ## ## ## ## ## India ## ## ## ## ## ## Brazil ## ## ## ## ## ## Mexico ## ## ## ## ## ## Russia ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken

  • Clinical Trial
  • Opioid
  • Therapy
  • World
  • Product Initiative

Therapy Area Cardiovascular Central Nervous System Dermatology Gastrointestinal Infectious Disease Metabolic Disorders Musculoskeletal Oncology Respiratory No. of Deals ## ## ## ## ## ## ## ## ## Deal Value (US$ million) NA NA N

  • Healthcare
  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • United States
  • World
  • CHRONIC PAIN - PIPELINE BY CYCLENIUM PHARMA, INC., H2 2016

The company' s preclinical pipeline includes antiviral and oncology targets, antiviral targets, multiple oncology targets, antibacterial and antifungal targets, and target against pain.

  • Opioid
  • Research And Development
  • United States
  • Company
  • Company Operations

The antiviral effect was induced without causing cell toxicity in the control vero cells.

  • Analgesic
  • Opioid
  • United States
  • Company
  • Product Initiative

The company' s preclinical pipeline includes antiviral and oncology targets, antiviral targets, multiple oncology targets, antibacterial and antifungal targets, and target against pain.

  • Chronic Pain
  • Opioid
  • Research And Development
  • United States
  • Company Operations

AYX-## inhibits the early growth response gene ## (EGR-##).

  • Chronic Disease
  • Opioid
  • United States
  • Company
  • Product Initiative